Skip to main content
. 2018 Mar 25;9(4):197–205. doi: 10.1177/2042098618760939

Table 2.

Characteristics of the adverse drug reaction reports on the four most common MedDRA organ system class of tapentadol and oxycodone/naloxone.

Nervous system disorders Psychiatric disorders General disorders and administration site conditions Gastrointestinal disorders
Tapentadol n = 52 (50%) (69 reaction terms)* n = 34 (32.7%) (38 reaction terms)* n = 21 (20.2%) (24 reaction terms)* n = 18 (17.3%) (24 reaction terms)*
Serotonin toxicity, n = 16 (23.2)**
Dizziness, n = 6 (8.7)
Tremor, n = 6 (8.7)
Other, n = 41 (59.4)
Delirium, n = 7 (18.4) Hallucination, n = 5 (13.1)
Confusional state, n = 5 (13.1)
Other, n = 21 (68.4)
Malaise, n = 5 (20.8)
Drug ineffective, n = 4 (16.6)
Other, n = 15 (41.6)
Nausea, n = 10 (41.6)
Abdominal pain upper, n = 2 (8.3)
Vomiting, n = 2 (8.3)
Other, n = 10 (41.6)
Age, mean 51.4 51.7 46.3 43.3
Missing age 22 11 7 5
Female sex, n 36 19 13 12
Missing sex 2 2 2 2
Causality possible, n 52 34 21 18
Outcome, n
Recovered 25 22 15 10
Not yet recovered 2 0 0 0
Death 1 0 0 1
Outcome missing 24 12 6 7
Oxycodone/Naloxone n = 62 (24.9%) (84 reaction terms)* n = 78 (31.3%) (129 reaction terms)* n = 87 (35%) (108 reaction terms)* n = 73 (29.3%) (116 reaction terms)*
Dizziness, n = 9 (10.7)
Somnolence, n = 8 (9.5)
Tremor, n = 8 (9.5)
Other, n = 59 (70.2)
Hallucinations, n = 22 (17)
Delirium, n = 12 (9.3)
Withdrawal syndrome, n = 12 (9.3)
Other, n = 83 (64.3)
Drug withdrawal syndrome, n = 28 (26)
Drug ineffective, n = 9 (8.3)
Other, n = 71 (65.8)
Nausea, n = 24 (20.7)
Diarrhoea, n = 23 (19.9)
Other, n = 69 (59.5)
Age, mean 64.1 64.4 58.4 61.0
Missing age 7 18 24 19
Female sex, n 41 42 56 51
Missing sex 0 1 0 1
Causality possible, n 62 78 87 73
Outcome, n
Recovered 32 45 48 42
Not yet recovered 6 10 8 11
Recovering 2 4 4 0
Death 2 1 2 1
Unrelated death 0 0 1 1
Outcome missing 20 18 24 18
*

Serotonin toxicity, n = 14 involved the use of one or more serotonergic agents (e.g. tramadol, duloxetine, venlafaxine, amitriptyline, sertraline, desvenlafaxine, escitalopram).

**

More than 1 reaction term can appear per report.

MedDRA, Medical Dictionary for Regulatory Activities.